CNTB SCHEDULE 13G/A: SEC filing
Connect Biopharma Holdings Ltd
Filed with the SEC on · accession 0001664985-26-000003
CNTB filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 3, 2026. Connect Biopharma Holdings Ltd filed an amended Schedule 13G, indicating a change in a passive institutional holder's ownership position.
Summary of the filing
Connect Biopharma Holdings Ltd filed an amended Schedule 13G, indicating a change in a passive institutional holder's ownership position. The filing does not disclose specific ownership percentages or share counts in the provided text.
Key details
✦ Ask GOAX AI about this filing — what it means for CNTB, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CNTB?
Click hereFrequently asked questions
What did CNTB file with the SEC on Nov 3, 2026?
CNTB filed a SCHEDULE 13G/A (SEC filing). Connect Biopharma Holdings Ltd filed an amended Schedule 13G, indicating a change in a passive institutional holder's ownership position. The filing does not disclose specific ownership percentages or share counts in the provided text.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other CNTB SEC filings
Get alerts when CNTB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days